NDC 15631-0002

ABROTANUM

Abrotanum

ABROTANUM is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc. The primary component is Artemisia Abrotanum Flowering Top.

Product ID15631-0002_9e337ed6-3570-8699-e053-2a95a90a8a19
NDC15631-0002
Product TypeHuman Otc Drug
Proprietary NameABROTANUM
Generic NameAbrotanum
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2015-08-28
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameRxhomeo Private Limited d.b.a. Rxhomeo, Inc
Substance NameARTEMISIA ABROTANUM FLOWERING TOP
Active Ingredient Strength1 [hp_X]/1
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 15631-0002-0

100 PELLET in 1 PACKAGE (15631-0002-0)
Marketing Start Date2018-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 15631-0002-1 [15631000201]

ABROTANUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-02-10

NDC 15631-0002-0 [15631000200]

ABROTANUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-02-10

NDC 15631-0002-2 [15631000202]

ABROTANUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-02-10

NDC 15631-0002-5 [15631000205]

ABROTANUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-02-10

NDC 15631-0002-4 [15631000204]

ABROTANUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-02-10

NDC 15631-0002-3 [15631000203]

ABROTANUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-02-10

Drug Details

Active Ingredients

IngredientStrength
ARTEMISIA ABROTANUM FLOWERING TOP1 [hp_X]/1

OpenFDA Data

SPL SET ID:0d6391b2-8af7-488e-8220-da7774b0666f
Manufacturer
UNII

NDC Crossover Matching brand name "ABROTANUM" or generic name "Abrotanum"

NDCBrand NameGeneric Name
0220-0014AbrotanumARTEMISIA ABROTANUM FLOWERING TOP
15631-0002ABROTANUMABROTANUM
15631-2301ABROTANUMABROTANUM
53645-1960AbrotanumAbrotanum
60512-6438ABROTANUMABROTANUM
63545-334AbrotanumAbrotanum
63545-709AbrotanumAbrotanum
63545-710AbrotanumAbrotanum
63545-711AbrotanumAbrotanum
63545-712AbrotanumAbrotanum
63545-713AbrotanumAbrotanum
68428-173AbrotanumAbrotanum
71919-003AbrotanumAbrotanum
63545-715AbrotanumAbrotanum
63545-714AbrotanumAbrotanum
63545-716AbrotanumAbrotanum
63545-789AbrotanumAbrotanum

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.